| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-316-77 | 59651-316 | HUMAN PRESCRIPTION DRUG | Tizanidine Hydrochloride | Tizanidine Hydrochloride | CAPSULE | ORAL | 20200324 | N/A | ANDA | ANDA213544 | Aurobindo Pharma Limited | TIZANIDINE HYDROCHLORIDE | 6 mg/1 | 150 CAPSULE in 1 BOTTLE (59651-316-77) |
| 59651-315-77 | 59651-315 | HUMAN PRESCRIPTION DRUG | Tizanidine Hydrochloride | Tizanidine Hydrochloride | CAPSULE | ORAL | 20200324 | N/A | ANDA | ANDA213544 | Aurobindo Pharma Limited | TIZANIDINE HYDROCHLORIDE | 4 mg/1 | 150 CAPSULE in 1 BOTTLE (59651-315-77) |
| 59651-314-77 | 59651-314 | HUMAN PRESCRIPTION DRUG | Tizanidine Hydrochloride | Tizanidine Hydrochloride | CAPSULE | ORAL | 20200324 | N/A | ANDA | ANDA213544 | Aurobindo Pharma Limited | TIZANIDINE HYDROCHLORIDE | 2 mg/1 | 150 CAPSULE in 1 BOTTLE (59651-314-77) |